SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunoGen
IMGN 31.230.0%Feb 26 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gary Mohilner who wrote (2979)4/3/2000 12:45:00 PM
From: Chi Wong  Read Replies (1) of 5665
 
Gary, what do you believe (best case scenario) would be the shortest possible time frame to begin phase III?

I believe once IMGN achieves recognition for the technology that is behind c242 and the potential for future partnerships due to the ability of TAPs to improve the effectiveness of other companies cancer fighters we could experience a significant revaluation of IMGN that would leave us all breathless. I also believe this will happen before we begin phase III for c242.

Can someone correct my beliefs?

thanks
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext